PED1003/L15 Anti-Parkinson's Drugs Flashcards

1
Q

What is the difference between Parkinson’s Disease and Parkinsonism?

A

PD - idiopathic disease
Parkinsonism - drug-, stroke-, infection-induced symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Give 3 symptoms of Parkinson’s Disease.

A

Motor symptoms
Resting tremor
Muscle rigidity
Suppression of voluntary movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the post-mortem neuropathology of Parkinson’s Disease.

A

Loss of DA cell bodies in substantia nigra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the presentation of PET images in a patient with Parkinson’s

A

Loss of DA terminals (tail) in striatum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the pathology of Parkinson’s Disease. (2)

A

Degeneration of DAergic neurones of nigrostriatal tract
Loss of DA neurotransmission in striatum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the pathology of Parkinsonism. (2)

A

Loss of DA transmission in striatum
Pharmacological blockade, brain lesion etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give 3 of the 4 dopaminergic pathways.

A

Nigrostriatal
Mesolimbic
Mesocortical
Tuberoinfundibular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the healthy nigrostitial system. (3)

A

Cell bodies in SN fire AP to striatum
Dopamine released into SC
In striatal output neurones, D2 receptor binding inhibits AP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the nigrostitial system in Parkinson’s Disease. (3)

A

Cell bodies in SN fire AP to striatum
Decreased DA release
Less inhibition of AP in striatum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe dopamine synthesis. (2)

A

Tyrosine -> L-DOPA via tyrosine hydroxylase
L-DOPA -> Dopamine via DOPA decarboxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is dopamine transported and stored?

A

VMAT transports DA into vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is dopamine metabolised?

A

By monoamine oxidase (MAO) outside the vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the metabolic pathway of dopamine. (3)

A

DA -> DOPAL via monoamine oxidase
DOPAL -> DOPAC via aldehyde dehydrogenase
DOPAC -> HVA via catechol-O-methyl transferase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Where are the 2 isoforms of monoamine oxidase found?

A

Both on X chromosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DA is mainly metabolised by which isoform of MAO?

A

MAO(B)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What kind of receptor are all dopamine receptors?

A

G-protein coupled receptors

17
Q

Give the 2 types of dopamine receptor and their action.

A

D1-like: excitatory
D2-like: inhibitory

18
Q

How is dopamine reuptaken?

A

By transporter (DAT)
12-span transmembrane protein

19
Q

Why is L-DOPA given to treat Parkinson’s? (3)

A

Intermediate in DA synthesis
Bypasses rate-limiting step
Increases DA synthesis

20
Q

Why is L-DOPA given with carbidopa? (2)

A

Carbidopa is a peripherally acting decarboxylase inhibitor
Stops dopamine synthesis in periphery

21
Q

Why can’t dopamine be given to treat Parkinson’s? (3)

A

Polar so can’t cross membranes
Metabolised by MAO in gut
Can give sympathomimetic effects (NA-like)

22
Q

How does selegiline help treat Parkinson’s? (3)

A

MAO(B) inhibitor
Blocks intraneuronal metabolism of DA
Increases DA content of vesicles

23
Q

How do D2 receptor agonists help to treat Parkinson’s?

A

Inhibit striatal output neurones directly

24
Q

Give an example of a D2 agonist.

A

Bromocriptine

25
Q

Give 2 side effects of D2 agonist drugs.

A

Psychosis
Cognitive dysfunction
Addictions

26
Q

Describe how antipsychotic drugs can cause Parkinsonism. (2)

A

Block D2 receptor in all 4 pathways
Decreased neurotransmission and increased AP firing in striatum